ZS Pharma (ZSPH) Posts Q2 Loss of $4.72/Share

ZS Pharma (NASDAQ: ZSPH) reported Q2 EPS of ($4.72), $4.06 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities